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FcRn is mother’s milk to allergen tolerance
In this issue Ohsaki et al. (https ://doi .org /10 .1084 /jem .20171163) explain how breastfeeding can prevent the onset of food 
allergies in offspring by instructing T reg formation via neonatal Fc receptor (FcRn)–mediated transfer and uptake of allergen-
containing IgG immune complexes (Ig-ICs) by gut dendritic cells (DCs).
Allergy is characterized by the presence 
of serum IgE antibodies to common 
and harmless environmental and food 
allergens and can lead to allergic dis-
eases like asthma, rhinitis, food allergy, 
and anaphylaxis. As allergy is highly 
prevalent is Western societies, and there 
seems to be no halt to the epidemic of 
food allergy, there is an urgent need for 
preventive strategies (Lambrecht and 
Hammad, 2017). Breastfeeding has long 
been shown to have protective effects 
on allergy development, yet protection 
seems to depend on whether the nurs-
ing mother is allergic or not and by ex-
tension whether the baby has high or 
low risk to develop disease (Munblit 
and Verhasselt, 2016). Yet other stud-
ies showed that breastfeeding can also 
promote allergies in babies, by allowing 
the transfer of allergens from the moth-
er’s diet. Maternal allergen avoidance 
during breastfeeding has therefore been 
a common recommendation to prevent 
the onset of allergies in high-risk babies 
born to allergic parents. However, recent 
data suggest that early life allergen avoid-
ance during the period of breastfeeding 
does not pay off and that certain food 
allergens should be introduced early in a 
diet to prevent food allergies (Du Toit et 
al., 2015). Given these controversies, in 
this issue, Ohsaki et al. studied whether 
and how maternal allergy to ovalbumin 
(OVA; a major allergen in egg) or pea-
nut affects the onset of allergy in their 
offspring. To induce allergy to foods, 
Ohsaki et al. (2018) sensitized mice 
via the epicutaneous route before and 
during pregnancy and during breast-
feeding. When the offspring of these 
allergic mothers reached adulthood, 
they were also sensitized epicutaneously 
and given an oral challenge with aller-
gen. Epicutaneous sensitization to food 
allergens is a highly relevant model, as 
peanut allergy in children often develops 
via a leaky skin barrier, and many food 
allergens like peanut are found in the 
household environment or as contam-
inants in baby skin lotions. The choice 
of OVA as a model allergen was also 
driven by the clinical observation that 
allergy to egg in early life is one of the 
strongest predictors of progression in the 
atopic march, the process by which chil-
dren gradually develop severe allergic 
diseases like atopic dermatitis, rhinitis, 
and asthma. Remarkably, the offspring 
of allergic mothers was tolerant to food 
allergen challenge, whereas those born 
out of control nonallergic mothers de-
veloped signs of systemic anaphylaxis, 
a life-threatening form of food allergy. 
The tolerant offspring mice had devel-
oped allergen-specific Foxp3+ T reg cells 
that expanded in response to allergen 
exposure and suppressed anaphylaxis to 
food allergen challenge even in 3-mo-
old offspring, when maternal-derived 
antibodies had long disappeared. Elegant 
setup of breeding and fostering of mice 
revealed that the protective T reg cells 
were induced mainly as a result of trans-
fer of maternal allergen IgG immune 
complexes (Ig-ICs) via breastfeeding of 
the pups and less efficiently via direct 
transplacental transfer. Supplementation 
of lactating mice with allergen IgG1-IC 
was sufficient to confer protection in off-
spring. The neonatal Fc receptor FcRn 
is well known to mediate the transfer of 
Igs from mother to child via placenta and 
breastfeeding to suckling mice, imply-
ing a role of FcRn in mother and child. 
When only the offspring was deficient 
in FcRn, the induction of T reg cells 
and functional tolerance to food aller-
gen offered by maternal allergen Ig-IC 
was abolished. Gut dendritic cells (DCs) 
express the FcRn receptor and were able 
to induce OVA-specific Foxp3+ T reg 
cells in response to exposure to breast 
milk–derived OVA Ig-ICs in vitro and 
ex vivo. Strikingly, mice lacking FcRn 
selectively in CD11chi DCs were un-
able to mount T reg cells and tolerance 
to food allergens via maternal protec-
tion. Ohsaki et al. (2018) finally made 
an important translational leap and fed 
humanized FcRn transgenic mice with 
breast milk of healthy nonatopic moth-
ers. This source of breast milk was rich 
in OVA-specific IgG4-IC. Although this 
experiment was performed by oral ga-
vage in adult mice, human breast milk 
suppressed the salient features of food 
allergy, including systemic anaphylaxis, 
suggesting that the mouse findings of 
the study likely translate to the human 
situation.
Breast milk has many benefi-
cial effects on the progeny’s develop-
ing immune system, much more than 
passively protecting the offspring form 
infectious disease by passive transfer of 
maternal protective antibodies and in-
fluencing the composition of the infant 
gut microbiome and gut barrier func-
tion. Breastfeeding can shape the neo-
natal repertoire of T cells and B cells by 
transfer of free antigen, including such 
potent allergens like house dust mite 
and peanut. The current study is not the 
first to report that allergen Ig-ICs from 
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2an allergic mother protect the progeny 
against allergic disease via breastfeeding 
and FcRn and induction of Foxp3+ T 
reg cells (Mosconi et al., 2010; Nakata 
et al., 2010; Bernard et al., 2014). In the 
past it was found that TGFβ contained 
in breast milk could be decisive whether 
or not long-lasting T reg–mediated tol-
erance developed, but when Ig-ICs are 
present in breast milk, TGFβ does not 
seem to be required (Verhasselt et al., 
2008). So where does the current study 
add novelty? In previous work, the role 
of FcRn was merely seen as a transfer 
receptor mediating the transepithe-
lial uptake of allergen Ig-ICs from the 
lumen to the immune system’s DCs or 
macrophages, a known function of this 
receptor (Yoshida et al., 2004). How-
ever, in mice and humans, the FcRn is 
also expressed by DCs and macrophages 
(Guilliams et al., 2014), and it turns out 
increasingly that FcRn is crucial in de-
termining the immunological outcome 
of an Ig-IC encounter (Stapleton et al., 
2015). When IgG or and Ig-IC binds to 
activating Fc receptors on APCs, it is in-
ternalized in endosomes that undergo a 
gradual drop in pH. At a lower pH 6.5, 
the FcRn receptor has increased affinity 
for the constant domains of IgG. In the 
case of free IgG, this leads to recycling 
of the IgG to the cell membrane, fol-
lowed by exocytosis, thus extending the 
half-life of IgG considerably. Binding 
of Ig-IC to FcRn and interaction with 
the invariant chain CD74 promote the 
routing of the Ig-IC to the MHC II-rich 
processing and loading compartment for 
presentation of peptides on MHC II to 
CD4 T cells (Qiao et al., 2008). It has 
also been shown that FcRn in DCs pro-
motes the cross-presentation of Ig-IC by 
protecting antigens in an acidic endoso-
mal environment and allowing transfer 
of undigested protein epitopes to the 
cytoplasm for further trimming by the 
proteasome (Baker et al., 2011). Ohsaki 
et al. (2018) suggest that FcRn might 
also act to promote tolerance, although 
the mechanism of such tolerance induc-
tion requires much more detailed anal-
ysis. It will be important to study which 
APCs among the CD11c targeted cells 
is mediating T reg tolerance in the gut. 
Various APCs can mediate food toler-
ance in the intestine of adult mice, but 
T reg formation seems to be particularly 
induced by macrophages closely col-
laborating with CD103+ conventional 
cDC1 (Mazzini et al., 2014). FcRn often 
does not work in isolation, but requires 
collaboration with activating or inhibi-
tory Fc receptors for signaling and in-
ternalization of the Ig-ICs. Although 
the inhibitory Fc receptor FcγRIIb 
has a role in oral tolerance induction 
to common foods and is expressed by 
conventional DCs, it was shown that it 
was not required for tolerance induction 
by breast milk Ig-ICs in suckling mice 
(Samsom et al., 2005; Mosconi et al., 
2010). Activating Fc receptors are there-
fore more likely candidates, but these are 
poorly expressed on conventional DCs, 
suggesting an important contribution 
of monocyte-derived cells and macro-
phages that highly express activating Fc 
receptors (Guilliams et al., 2014). Finally, 
the translational part of the study shows 
that ICs containing IgG4 and allergen 
confer protection from food allergy in 
adult mice in an FcRn-dependent man-
ner. Induction of allergen-specific IgG4 
is often seen in patients undergoing 
successful subcutaneous or sublingual 
allergen immunotherapy, or those who 
spontaneously tolerate high loads of 
allergen exposure like bee keepers and 
cat owners, likely also leading to forma-
tion of allergen Ig-ICs. It will be very 
important to study whether FcRn on 
DCs is involved in this particular state 
of tolerance to allergens. Studying the 
molecular details of the interaction of 
FcRn with IgG is certainly on the radar 
of drug companies who use this knowl-
edge to improve the half-life of thera-
peutic antibodies that recycle via FcRn. 
It might therefore not be too long before 
we see therapeutic applications of toler-
ance promoting immune complexes that 
target FcRn.
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FcRn-dependent manner. Triggering of the FcRn on DCs led to the formation of allergen-
specific CD4+ Foxp3+ T reg cells. When the offspring mice reached adulthood, they were 
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dependent manner in the neonatal period were able to suppress anaphylaxis. In mice born 
to nonallergic mothers, the allergen challenge led to signs of severe anaphylaxis.
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